These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19419768)

  • 101. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
    Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
    Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins].
    Jansen AG; Noordzij JG; Bröcker-Vriends AH; van Dongen JJ; van Tol MJ; Bredius RG
    Ned Tijdschr Geneeskd; 2004 May; 148(21):1053-6. PubMed ID: 15185441
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
    Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
    Brunner C; Kreth HW; Ochs HD; Schuster V
    J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia.
    Vu QV; Wada T; Le HT; Le HT; Van Nguyen AT; Osamu O; Yachie A; Nguyen SN
    BMC Pediatr; 2014 May; 14():129. PubMed ID: 24885015
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Agammaglobulinemia: from X-linked to Autosomal Forms of Disease.
    Cardenas-Morales M; Hernandez-Trujillo VP
    Clin Rev Allergy Immunol; 2022 Aug; 63(1):22-35. PubMed ID: 34241796
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report.
    Srinivasan C; Shameli A; Ritchie B; Adatia A
    Immun Inflamm Dis; 2023 Oct; 11(10):e1049. PubMed ID: 37904676
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital.
    Chun JK; Lee TJ; Song JW; Linton JA; Kim DS
    Yonsei Med J; 2008 Feb; 49(1):28-36. PubMed ID: 18306466
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia.
    Bahal S; Zinicola M; Moula SE; Whittaker TE; Schejtman A; Naseem A; Blanco E; Vetharoy W; Hu YT; Rai R; Gomez-Castaneda E; Cunha-Santos C; Burns SO; Morris EC; Booth C; Turchiano G; Cavazza A; Thrasher AJ; Santilli G
    J Allergy Clin Immunol; 2024 Jul; 154(1):195-208.e8. PubMed ID: 38479630
    [TBL] [Abstract][Full Text] [Related]  

  • 110. COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency.
    Ponsford MJ; Shillitoe BMJ; Humphreys IR; Gennery AR; Jolles S
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):525-534. PubMed ID: 34596095
    [TBL] [Abstract][Full Text] [Related]  

  • 111. X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry.
    O'Toole D; Groth D; Wright H; Bonilla FA; Fuleihan RL; Cunningham-Rundles C; Sullivan KE; Ochs HD; Marsh R; Feuille E
    J Clin Immunol; 2022 May; 42(4):827-836. PubMed ID: 35288819
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Gastrointestinal Manifestations in X-linked Agammaglobulinemia.
    Barmettler S; Otani IM; Minhas J; Abraham RS; Chang Y; Dorsey MJ; Ballas ZK; Bonilla FA; Ochs HD; Walter JE
    J Clin Immunol; 2017 Apr; 37(3):287-294. PubMed ID: 28236219
    [TBL] [Abstract][Full Text] [Related]  

  • 113. First report of Wilson disease and Bruton agammaglobulinemia in the same patient caused by new mutations in
    Olaya-Hernandez M; Aristizábal-Henao C; Perez-Camacho P; Patiño-Niño J; Medina-Valencia D; Botero-Osorio V; Pachajoa H
    Allergol Immunopathol (Madr); 2023; 51(3):108-110. PubMed ID: 37169567
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A novel
    Lee J; Rhee M; Min TK; Bang HI; Jang MA; Kang ES; Kim HJ; Yang HJ; Pyun BY
    Korean J Pediatr; 2016 Nov; 59(Suppl 1):S49-S52. PubMed ID: 28018445
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Hemizygous BTK Gene Variant Causing X-Linked Agammaglobulinemia in Two Siblings.
    Saheb Sharif-Askari N; Hafezi S; Saheb Sharif-Askari F; Frommenwiler N; Halwani R
    J Clin Immunol; 2023 Oct; 43(7):1533-1536. PubMed ID: 37341860
    [No Abstract]   [Full Text] [Related]  

  • 116. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication.
    Nunes-Santos CJ; Koh C; Rai A; Sacco K; Marciano BE; Kleiner DE; Marko J; Bergerson JRE; Stack M; Rivera MM; Constantine G; Strober W; Uzel G; Fuss IJ; Notarangelo LD; Holland SM; Rosenzweig SD; Heller T
    J Allergy Clin Immunol; 2022 Jan; 149(1):400-409.e3. PubMed ID: 34087243
    [TBL] [Abstract][Full Text] [Related]  

  • 117. IgA nephropathy in a child with X-linked agammaglobulinemia: a case report.
    Song Y; Sun L; Feng D; Sun Q; Wang Y
    BMC Pediatr; 2024 Apr; 24(1):291. PubMed ID: 38689221
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Novel BTK Mutation in Patient with Late Diagnosis of X-Linked Agammaglobulinemia.
    Kalkat A; Humpel O; Hostoffer R
    Case Reports Immunol; 2023; 2023():6698913. PubMed ID: 38046560
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Concomitant diagnosis of immune deficiency and
    Sanford E; Farnaes L; Batalov S; Bainbridge M; Laubach S; Worthen HM; Tokita M; Kingsmore SF; Bradley J
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559311
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Atypical phenotype? The answer's in the genotype: AGS caused by a novel RNASEH2C variant combined with XLA caused by a BTK deficiency.
    Boulanger C; Chatzis O; Nolf D; Brichard B; Lauwerys B; Nassogne MC; Limaye N
    Rheumatology (Oxford); 2021 Jul; 60(7):e240-e242. PubMed ID: 33471103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.